Risk factors for persistent bacteremia in patients with GNB BSI: an SR with meta-analysis
Do you do a FUBC in GNB patients? @alif82 (something that might interest you)
QnA: How freq was the FUBC in these studies?
Variable ways of FUBC in all the included studies
SAB management updates by IDSA/ESCMID
#ESCMIDGlobal2024
The term “complicated” SAB varies and does not always suggest longer treatment
Solution: low vs. high-risk populations for SAB
How do we risk stratify SAB into the two levels?
How many sets of BC should be repeated?
1 or 2 sets
24 or 48 hours later
A very enlightening talk by Angela Hutner on simple vs complicated UTI definitions
Simplicity wins
Anything that is beyond the bladder = complicated UTI (including prostatitis)
This will be updated in 2024 by both the IDSA and ESCMID
New drugs against GNB by Ursula Theuretzbacher #ECCMID2023
In Malaysia, we only have Cefta-avi for resistant GNB infections!
We hope @SHIONOGI_JP will include Malaysia in the list of countries for generic cefiderocol- a project by @gardp_amr
These are the drugs that are recently approved and we have none of these locally
We can only use Fe-troja(n)/Cefiderocol by @SHIONOGI_JP under the compassionate use program, and the drug is flown all the way from Europe
The cost is huge and our patients can rarely afford it
Again, the same table:
The red ones are called DBO/Diazabicyclooctanes. They have an added PBP activity in addition to BLI activity
Boronates have extended BLI activity (MBL)
The green one is the Tazobactam analogue